tiprankstipranks
Pharmadrug (TSE:PHRX)
:PHRX
Canadian Market
Want to see TSE:PHRX full AI Analyst Report?

Pharmadrug (PHRX) Financial Statements

33 Followers

Pharmadrug Financial Overview

Pharmadrug's market cap is currently C$1.34M. The company's EPS TTM is C$-0.0043; its P/E ratio is -2.33; Pharmadrug is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 7.01K
Gross ProfitC$ -50.24KC$ -50.24KC$ -26.22KC$ -2.26KC$ -2.15K
Operating IncomeC$ -225.93KC$ -668.66KC$ -1.33MC$ -2.43MC$ -2.80M
EBITDAC$ -71.98KC$ -549.04KC$ -1.33MC$ -2.34MC$ -4.21M
Net IncomeC$ -383.38KC$ -793.27KC$ -13.20MC$ -8.88MC$ -5.87M
Balance Sheet
Cash & Short-Term InvestmentsC$ 23.24KC$ 75.04KC$ 423.06KC$ 329.24KC$ 1.30M
Total AssetsC$ 551.66KC$ 711.80KC$ 1.20MC$ 12.11MC$ 19.52M
Total DebtC$ 1.52MC$ 1.35MC$ 1.77MC$ 1.42MC$ 866.37K
Net DebtC$ 1.50MC$ 1.27MC$ 1.36MC$ 1.41MC$ -91.62K
Total LiabilitiesC$ 2.20MC$ 1.96MC$ 2.66MC$ 3.28MC$ 2.66M
Stockholders' EquityC$ -1.76MC$ -1.40MC$ -1.70MC$ 8.84MC$ 16.87M
Cash Flow
Free Cash FlowC$ -87.51KC$ -768.60KC$ -671.88KC$ -2.26MC$ -4.17M
Operating Cash FlowC$ -87.51KC$ -756.62KC$ -671.88KC$ -2.26MC$ -4.13M
Investing Cash FlowC$ 0.00C$ -11.98KC$ 995.04KC$ 77.58KC$ 1.48M
Financing Cash FlowC$ 0.00C$ 321.56KC$ 225.51KC$ 843.25KC$ 776.97K
Currency in CAD

Pharmadrug Earnings and Revenue History

Pharmadrug Debt to Assets

Pharmadrug Cash Flow

Pharmadrug Forecast EPS vs Actual EPS